Semaglutide commonly causes mild nausea, constipation, or decreased appetite for certain foodseffects that diminish as your body adapts over 2-3 weeks
Hyponatraemia (low sodium) is a recognised risk with SSRIs like escitalopram, which may be compounded by dehydration from GLP-1related gastrointestinal effects
In type 2 diabetes with chronic kidney disease, semaglutide slowed kidney-disease progression by about 24%. One milligram is a modest weight-loss dose but a proven kidney dose for that population
Improved blood sugar control, particularly beneficial for patients with type 2 diabetes or prediabetes
As we age, NAD+ levels drop, leading to fatigue, inflammation, and brain fog
What is the listed molecular weight of Melanotan II